Haisco Pharmaceutical Group Co., Ltd.
115
25
29
56
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 115 trials
100.0%
+13.5% vs industry average
24%
28 trials in Phase 3/4
0%
0 of 56 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (115)
Evaluating the Efficacy and Safety of of HSK50042 in People With Idiopathic Pulmonary Fibrosis
Role: lead
HSK41959 With Standard Therapy in Solid Tumors With MTAP Deletion
Role: lead
Ciprofol vs Propofol for Hemodynamic Stability in Patients Having General Anesthesia for Endovascular Thrombectomy After Ischemic Stroke
Role: collaborator
A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of HSK46256 in Patients With Advanced Solid Tumors
Role: lead
Preventive Analgesia With Anrikefon in Laparoscopic Cholecystectomy
Role: collaborator
First-in-human Study of HSK56630 in Healthy Subjects
Role: lead
To Evaluate the Efficacy and Safety of HSK31679 in Chinese Patients With Non-Alcoholic Steatohepatitis (NASH) .
Role: lead
A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of HSK39004 Inhalation Suspension in Patients With COPD
Role: lead
A Phase 3 Study Evaluating the Safety and Efficacy of HSK31679 in Patients With MASH
Role: lead
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase III Study of HSK39004 Inhalation Powder for the Treatment of COPD
Role: lead
Evaluation of the Safety and Efficacy of HSK39004 Dry Powder Inhaler and HSK39004 Inhalation Suspension in Chinese Patients With Chronic Obstructive Pulmonary Disease (COPD)
Role: lead
Trial of HSK44459 Cream for the Management Plaque Psoriasis
Role: lead
Long-Term Safety and Efficacy of HSK39004 Inhalation Suspension in COPD
Role: lead
A Study to Assess the Safety of HSK31858 in Participants With Non-Cystic Fibrosis Bronchiectasis
Role: lead
A Study to Evaluate the Long-Term Safety and Efficacy of HSK39297 Tablets in Primary IgA Nephropathy
Role: lead
A Clinical Trial Evaluating the Efficacy and Safety of HSK55718 in Patients for Postoperative Pain Treatment in Abdominal Surgery
Role: lead
Phase Ⅲ Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients With Primary IgAN
Role: lead
Phase II Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients With Primary IgAN
Role: lead
Phase I Study of HSK42360-Na in Solid Tumors With BRAF V600 Mutation
Role: lead
Bioequivalence Study of Tenofovir Disoproxil Fumarate Tablets in Healthy Chinese Subjects
Role: lead